MabGenesis株式会社
PrivateLast Round
VC Round
Dec 24, 2024
Est. Valuation
$21.66M
Total Funding Raised
$2.57M
Company Overview
MabGenesis株式会社 operates in Healthcare & Life Sciences and is based in Yokohama. Its latest recorded funding round was a VC Round in December 2024.
MabGenesis株式会社 is a Japanese biotechnology company that develops therapeutic monoclonal antibody drugs for humans and companion animals.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MabGenesis株式会社 Comparables
Compare MabGenesis株式会社 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vetigenics Inc. | 80% | |
| iBody Inc. | 78% | |
| MOLCURE Inc. | 76% |
For institutional investors. Book with your work email.
MabGenesis株式会社 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 24, 2024 | ||||
| VC Round | Dec 2, 2022 | ||||
| Series A Extension | Jun 1, 2020 | ||||
| Seed | Jan 19, 2020 |
For institutional investors. Book with your work email.
MabGenesis株式会社 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beyond Next Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 24, 2024
$3M raised from venture capital and government investors.
- Nov 13, 2024
Monthly visitors increased 60% MoM.
For institutional investors. Book with your work email.
MabGenesis株式会社 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MabGenesis株式会社's valuation, stock price, and market status.
Is MabGenesis株式会社 a public or private company?
MabGenesis株式会社 is a private company.
What is the current stock price of MabGenesis株式会社?
MabGenesis株式会社 is a private company, so its shares have no public market price. Caplight tracks MabGenesis株式会社's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MabGenesis株式会社 worth (valuation)?
MabGenesis株式会社's valuation is estimated at $21.7M based on funding round data.
Can I buy MabGenesis株式会社 stock?
MabGenesis株式会社 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MabGenesis株式会社's last funding round?
MabGenesis株式会社's most recent funding round was VC Round on December 24, 2024.
Who are the main investors in MabGenesis株式会社?
Key investors in MabGenesis株式会社 include Beyond Next Ventures.
Will MabGenesis株式会社 IPO soon?
No public IPO plans have been announced for MabGenesis株式会社.
How can I track MabGenesis株式会社 secondary market activity?
Caplight tracks bids, offers, and trades in MabGenesis株式会社's shares on secondary markets.